Valuation: Aker BioMarine ASA

Capitalization 9.23B 992M 853M 779M 744M 1.35B 95.18B 1.39B 9.35B 3.62B 45.11B 3.72B 3.64B 157B P/E ratio 2026 *
60.3x
P/E ratio 2027 * 25.8x
Enterprise value 10.57B 1.14B 977M 892M 852M 1.55B 109B 1.59B 10.72B 4.15B 51.7B 4.27B 4.17B 180B EV / Sales 2026 *
4.55x
EV / Sales 2027 * 3.83x
Free-Float
10.69%
Yield 2026 *
-
Yield 2027 * -
1 day-1.13%
1 week+2.14%
Current month+4.78%
1 month+1.15%
3 months+5.73%
6 months+29.72%
Current year+6.59%
1 week 100
Extreme 100
108.8
1 month 95.6
Extreme 95.6
108.8
Current year 90.7
Extreme 90.7
118
1 year 55
Extreme 55
118
3 years 30.35
Extreme 30.35
118
5 years 30.35
Extreme 30.35
118
10 years 30.35
Extreme 30.35
129.08
Manager TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 49 2018-07-31
Investor Relations Contact - 2023-05-31
Director TitleAgeSince
Chairman 49 2013-12-31
Director/Board Member 56 2022-12-31
Director/Board Member 37 2020-12-31
Change 5d. change 1-year change 3-years change Capi.($)
-1.13%+2.14%+72.46%+180.53% 1.01B
0.00%-7.31%-10.02%-19.83% 14.79B
-1.04%-2.56%-28.30%-5.94% 4.84B
-0.28%-3.98%-24.27%-4.74% 3.37B
-0.52%-2.19%+38.69%+31.72% 2.94B
+3.67%-4.78%+1,324.37%+1,514.29% 2.78B
-3.10%-0.81%+1.57%+8.25% 1.73B
-7.75%-13.48%+2.52%+20.38% 1.68B
+4.10%-2.31%+43.91%+128.83% 1.69B
-0.90%-0.90%+39.24%-3.93% 1.67B
Average -0.70%-2.19%+146.02%+184.96% 3.65B
Weighted average by Cap. -0.31%-3.69%+99.95%+120.74%

Financials

2026 *2027 *
Net sales 2.32B 250M 215M 196M 187M 341M 23.96B 349M 2.35B 911M 11.36B 937M 917M 39.57B 2.67B 287M 247M 225M 215M 392M 27.55B 401M 2.71B 1.05B 13.06B 1.08B 1.05B 45.48B
Net income 152M 16.3M 14.01M 12.8M 12.23M 22.24M 1.56B 22.78M 154M 59.46M 741M 61.18M 59.88M 2.58B 358M 38.44M 33.05M 30.17M 28.83M 52.45M 3.69B 53.71M 362M 140M 1.75B 144M 141M 6.09B
Net Debt 1.35B 145M 124M 114M 109M 198M 13.89B 202M 1.37B 528M 6.59B 543M 532M 22.94B 1.01B 109M 93.44M 85.32M 81.51M 148M 10.43B 152M 1.02B 396M 4.94B 408M 399M 17.22B
Logo Aker BioMarine ASA
Aker Biomarine ASA is a Norway-based biotech innovator and Antarctic krill-harvesting company. It consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
Employees
258
Date Price Change Volume
26-05-15 105.20 kr -1.13% 116,227
26-05-13 106.40 kr +4.52% 28,780
26-05-12 101.80 kr -0.78% 8,361
26-05-11 102.60 kr -0.39% 9,464
26-05-08 103.00 kr 0.00% 5,678
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.29USD
Average target price
13.42USD
Spread / Average Target
+18.82%

Quarterly revenue - Rate of surprise